Author, Year |
Country |
Design of Study |
Types of Microorganisms |
Methodology |
Follow-up |
Age Range (y) |
Sample Size |
Reference |
Vermund, et al. 1991 [19] |
USA |
Cross-sectional |
HPV |
PCR |
- |
23-58 |
97 |
Miott, et al. 1996 [21] |
Malawi |
Cross-sectional |
HPV |
PCR |
1 year |
- |
284 |
Chiasson, et al. 1997 [47] |
USA |
Cross-sectional |
HPV |
PCR |
- |
>18 |
771 |
Uberti-foppa, et al. 1998 [23] |
Italy |
Cross-sectional |
HPV |
PCR |
1 year and 10 months |
21-64 |
268 |
Cu-uvin, et al. 1999 [2] |
USA |
Cohort |
BV |
Clinical examination |
1 year and 9 months |
16-55 |
1.31 |
HPV |
PCR |
Candida sp. |
Culture |
N. gonorrhoeae |
Serology |
Treponema pallidum |
Culture |
T. vaginalis |
Serology |
Chlamydia trachomatis |
|
Warren, et al. 2001 [39] |
USA |
Cohort |
Gardnerella sp. |
Gram |
1 year and 9 months |
16-55 |
1.31 |
BV |
Conley, et al. 2002 [22] |
USA |
Cohort |
HPV |
PCR |
6 years and 11 months |
16-35 |
925 |
Branca, et al. 2003 [26] |
Italy |
Cohort |
HPV |
PCR |
2 years |
17-45 |
142 |
Viscidi, et al. 2003 [27] |
USA |
Cohort |
HPV |
PCR |
1 year and 9 months |
16-55 |
2.559 |
Viscidi, et al. 2003b [28] |
USA |
cohort |
HPV |
PCR |
1 year and 9 months |
16-55 |
2.524 |
Ohmit, et al. 2003 [44] |
USA |
Cohort |
Candida sp. |
Culture |
1 year and 9 months |
16-55 |
1.31 |
Harris, et al. 2005 [29] |
USA |
Cohort |
HPV |
PCR |
1 year |
34-36 |
1.198 |
Watts, et al. 2005 [24] |
USA |
Cohort |
BV |
Nugent criteria |
1 year and 1 month |
- |
2.229 |
HPV |
PCR |
T. vaginalis |
Fresh examination |
Watts, et al. 2006 [25]. |
USA and Hawaii |
Cohort |
BV |
Gram |
1 year and 1 month |
- |
2.652 |
HPV |
PCR |
T. vaginalis |
Fresh examination |
Didelot-rousseau, et al. 2006 [31]. |
Bobo-Dioulasso |
Cross-sectional |
HPV |
PCR |
- |
16-54 |
379 |
Ng´andwe, et al. 2007 [32] |
Zambia |
Cohort |
HPV |
PCR |
1 year and 1 month |
15-38 |
70 |
sha 2007 [16] |
USA |
Cohort |
BV |
Nugent criteria |
1 years and 1 month |
- |
2.628 |
Candida sp. |
Smear with potassium hydroxide (KOH) |
T. vaginalis |
Fresh examination |
Singh, et al. 2009 [33] |
Rwanda |
Cohort |
HPV |
PCR |
6 months |
>25 |
936 |
Desruisseau, et al. 2010 [35] |
Camaroon |
Cross-sectional |
HPV |
PCR |
10 years and 11 months |
>18 |
65 |
Djigma, et al. 2011 [34] |
Burkina Faso |
Cohort |
Mycoplasma sp. |
PCR |
6 months |
27-45 |
451 |
Candida sp. |
Culture |
N. gonorrhoeae |
|
Nowark, et al. 2011 [45]. |
Zimbabue |
Cohort |
HSV-2 |
ELISA |
4 years and 2 months |
28-35 |
641 |
BV |
AMSEL CRITERIA |
HPV |
PCR |
N. gonorrhoeae |
|
Chlamydia trachomatis |
|
Gallo, et al. 2011 [40] |
USA |
Cohort |
BV |
Nugent criteria |
2 years |
16-55 |
1364 |
Oliveira, et al. 2011 [17] |
Brazil |
Cross- sectional |
Candida sp. |
Culture |
1 year |
>18 |
140 |
Chiduo, et al. 2012 [30] |
Tanzania |
Cohort |
Candida sp. |
Gram |
2 years |
>18 |
205 |
Treponema pallidum |
Serology |
T. vaginalis |
Fresh examination PCR |
Chlamydia trachomatis |
|
Blitz, et al. 2013 [36] |
Canada |
Cohort |
HPV |
PCR |
9 years |
15-44 |
923 |
Hu, et al. 2013 [18] |
USA |
Cohort |
Candida sp. |
Culture |
4 years and 5 months |
>18 |
24 |
Apalata, et al. 2014 [20] |
South Africa |
Cohort |
HSV-2 |
PCR |
7 months |
>18 |
198 |
Mycoplasma sp. |
Culture |
Candida sp. |
PCR |
N. gonorrhoeae |
|
T. vaginalis |
|
Chlamydia trachomatis |
|
Benning, et al. 2014 [41] |
USA and Rwandan |
Cohort |
N. gonorrhoeae |
Sequencing |
1 years and 10 months |
33-51 |
86 |
Mackelprang, et al. 2015 [43] |
USA |
Cross-sectional |
BV |
Nugent criteria |
- |
- |
372 |
Masson, et al. 2015 [42] |
South Africa |
Cross-sectional |
HSV-2 |
ELISA |
- |
18-59 |
265 |
BV |
Nugent criteria |
Mycoplasma sp. |
PCR |
N. gonorrhoeae |
Quick test |
Treponema pallidum |
PCR |
T. vaginalis |
|
Chlamydia trachomatis |
|
Alczuk, et al. 2015 [15] |
Unganda |
Cohort |
Candida sp. |
Culture |
4 years and 2 months |
18-35 |
641 |
Massad, et al. 2016 [37] |
USA |
Cohort |
HPV |
PCR |
8 years |
>18 |
3438 |
Reimers, et al. 2016 [38] |
USA |
Cohort |
HPV |
PCR |
8 years |
>18 |
64 |
Kriek, et al. 2016 [46] |
South Africa |
Cohort |
HPV |
PCR |
6 months |
28-42 |
165 |
Mycoplasma sp. |
N. gonorrhoeae |
T. vaginalis |
Chlamydia trachomatis |
Alcaide, et al. 2016 [14] |
USA |
Cross-sectional |
BV |
Nugent criteria |
8 months |
18-45 |
34 |